Response to comment on 'impact of routine clinic measurement of random serum C-peptide in people with a clinician diagnosis of type 1 diabetes' doi: 10.1111/dme.14449

Diabet Med. 2022 Jan;39(1):e14537. doi: 10.1111/dme.14537. Epub 2021 Feb 13.

Authors

Evgenia Foteinopoulou¹, Mark W J Strachan¹

Affiliation

¹ Metabolic Unit, Western General Hospital, Edinburgh, UK.

PMID: 33544923
DOI: 10.1111/dme.14537

No abstract available

Publication types

Letter
Comment

MeSH terms

C-Peptide
Diabetes Mellitus, Type 1* / diagnosis
Diabetes Mellitus, Type 2*
Diabetic Retinopathy*
Humans

Substances

C-Peptide